The a subunit of inhibin in adrenal cortical neoplasia

Modern Pathology

Volumn 11, Issue 6, 1998, Pages 516-524

  Pelkey, Timothy J ^a   Frierson Jr , Henry F ^a   Mills, Stacey E ^a   Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adrenal cortical tumors; Immunohistochemistry; Inhibin

Indexed keywords

INHIBIN; INHIBIN ALPHA SUBUNIT; INHIBIN-ALPHA SUBUNIT; PEPTIDE; TUMOR MARKER;

ADRENAL CORTEX TUMOR; ALPHA CHAIN; ANTIBODY LABELING; ARTICLE; DIFFERENTIAL DIAGNOSIS; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYPERALDOSTERONISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRECURSOR; PRIORITY JOURNAL; VIRILIZATION; ADENOMA; ADULT; AGED; CARCINOMA; CHEMISTRY; ENZYME IMMUNOASSAY; FEMALE; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; CARCINOMA; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBINS; MALE; MIDDLE AGED; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 0031595506     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 1989;44: 1-35.
2. Burger HG. Clinical utility of inhibin measurements. J Clin Endocrinol Metab 1993;76:1391-6.
3. Burger HG. Inhibin. Reprod Med Rev 1992;1:1-20.
4. Healy DL, Mamers P, Bangah M, Burger HG. Clinical and pathophysiologic aspects of inhibin. Hum Reprod 1993; 8(Suppl):138-40.
5. Haji M, Nishi Y, Tanaka S, Ohashi M, Sekiya K, Hasegawa Y, et al. Evidence for the secretion of inhibin-like immunoreactivity from cultured human adrenal cells [abstract]. J Endocrinol 1991;128:R13.
6. Spencer SJ, Rabinovici J, Mesiano S, Goldsmith PC, Jaffe RB. Activin and inhibin in the human adrenal gland. J Clin Invest 1992;90:142-9.
7. Voutilainen R. What is the function of adrenal inhibins? Eur J Endocrinol 1995;132:290-1.
8. Voutilainen R, Eramaa M, Ritvos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol 1991;73:1026-30.
9. Nishi Y, Haji M, Takayanagi R, Yanase T, Ikuyama S, Nawata H. In vivo and in vitro evidence for the production of inhibin-like immunoreactivity in human adrenocortical adenomas and normal adrenal glands: relatively high secretion from adenomas manifesting Cushing's syndrome. Eur J Endocrinol 1995;132:292-9.
10. Brennemann W, Klingmuller D, Eter N, Bidlingmaier F. Immunoreactive inhibin concentrations in human gonads and adrenals during the first years of life. Horm Res 1995;44:115-20.
11. Crawford RJ, Hammond VE, Evans BA, Coghlan JP, Haralambidis J, Hudson B, et al. α inhibin gene expression occurs in the ovine adrenal cortex, and is regulated by adrenocorticotropin. Mol Endocrinol 1987;1:699-706.
12. Demura R, Kubo O, Suzuki T, Yajima R, Tajima S, Takakura K, et al. Demonstration of activin in normal pituitary and in various human pituitary adenomas by immunohistochemistry. Endocr J 1996;43:429-32.
13. Pelkey TJ, Frierson HF, Mills SE, Stoler MH. The diagnostic utility of inhibin staining in ovarian neoplasia. Int J Gynecol Pathol 1998;17:97-105.
14. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, et al. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 1996;51:123-54.
15. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A. Development of the cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A 1994;91:8817-21.
16. Medeiros LJ, Weiss LM. New developments in the pathologic diagnosis of adrenal cortical neoplasms: a review. Am J Clin Pathol 1992;97:73-83.
17. Kleiber H, Rey F, Temler E, Gomez F. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome. J Endocrinol Invest 1991;14: 489-92.
18. Ambrosi B, Bochicchio S, Peverelli S, Ferrario R, Faglia G. Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy. J Endocrinol Invest 1992;15:827-35.
19. Mesiano S, Jaffe RB. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 1997;62:62-72.
20. Wick MR, Cherwitz DL, McGlennen RC, Dehner LP. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Am J Pathol 1986;122:343-52.
21. Cote RJ, Cardon-Cardo C, Reuter VE, Rosen PP. Immunopathology of adrenal and renal cortical tumors: coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol 1990;136:1077-84.
22. Miettinen M. Neuroendocrine differentiation in adrenocortical carcinoma: new immunohistochemical findings supported by electron microscopy. Lab Invest 1992;66:169-74.
23. Sasano H, Suzuki T, Nagura H, Nishikawa T. Steroidogenesis in human adrenocortical carcinoma: biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases. Hum Pathol 1993;24:397-404.
24. Schröder S, Padberg B-C, Achilles E, Holl K, Dralle H, Klöppel G. Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms. Virchows Arch A Pathol Anat Histopathol 1992;420:65-70.
25. Henzen-Logmans SC, Stel HV, Van Muijen GNP, Mullink H, Meijer CJLM. Expression of intermediate filament proteins in adrenal cortex and related tumours. Histopathology 1988; 12:359-72.
26. Gaffey MJ, Traweek ST, Mills SE, Travis WD, Lack EE, Medeiros LJ, et al. Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 1992;23:144-53.
27. Haak HR, Fleuren G-J. Neuroendocrine differentiation of adrenocortical tumors. Cancer 1995;75:860-4.
28. Komminoth P, Roth J, Schröder S, Saremaslani P, Heitz PU. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinoma: implications for the differential diagnosis of adrenal gland tumors. Lab Invest 1995;72:424-31.
29. Kimura N, Sasano N, Yamada R, Satoh J. Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour. Virchows Arch A Pathol Anat Histopathol 1988;413:33-8.
30. Silva EG, Mackay B, Samaan NA, Hickey RC. Adrenocortical carcinomas: an ultrastructural study of 22 cases. Ultrastruct Pathol 1982;3:1-7.
31. Saeger W. Pathology of adrenal neoplasms. Minerva Endocrinol 1995;20:1-8.
32. Schröder S, Niendorf A, Achilles E, Dietel M, Padberg BC, Beisiegel U, et al. Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal anti-body D11. Virchows Arch A Pathol Anat Histopathol 1990; 417:89-96.
33. Sasano H, Suzuki T, Nagura H, Nishikawa T. Steroidogenesis in human adrenocortical carcinoma: biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases. Hum Pathol 1993;24:397-404.
34. Sasano H, Shizawa S, Nagura H. Adrenocortical cytopathology. Am J Clin Pathol 1995;104:161-6.
35. Sasano H, Sato F, Shizawa S, Nagura H, Coughtrie MWH. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland. Mod Pathol 1995;8:891-6.
36. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenal cortical carcinoma. Cancer 1989;64:765-9.
37. Suzuki T, Sasano H, Sawai T, Tsunoda K, Nisikawa T, Abe K, et al. Small adrenocortical tumors without apparent clinical endocrine abnormalities. Pathol Res Pract 1992;188:883-9.
38. Zografos GC, Driscoll DL, Karakousis CP, Huben RP. Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol 1994;55: 160-4.
39. Grondal S, Cedermark B, Eriksson B, Grimelius L, Harach R, Kristoffersson A, et al. Adrenocortical carcinoma: a retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 1990;16:500-6.
40. Cohn K, Gottesman L, Brennan M. Adrenocortical carcinoma. Surgery 1986;100:1170-7.
41. Evans HL, Vassilopoulou-Sellin R. Adrenal cortical neoplasms: a study of 56 cases. Am J Clin Pathol 1996;105:76-86.
42. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM. Adrenocortical carcinoma: a clinical study and treatment results of 52 patients. Cancer 1995;75:2587-91.
43. Suzuki T, Sasano H, Sawai T, Tsunoda K, Nisikawa T, Jabe K, et al. Small adrenocortical tumors without apparent clinical endocrine abnormalities. Pathol Res Pract 1992;188:883-9.
44. Carballeira A, Fishman LM. Steroid enzyme activities in extra-adrenal pheochromocytomas. I Clin Endocrinol Metab 1982;54:619-24.
45. Alsabeh R, Mazoujian G, Goates J, Medeiros LJ, Weiss LM. Adrenal cortical tumors clinically mimicking pheochromocytoma. Am J Clin Pathol 1995;104:382-90.
46. Barton DE, Yang-Feng TL, Mason AJ, Seeburg PH, Francke U. Mapping of genes for inhibin subunits α, β A, and β B on human and mouse chromosomes and studies of jsd mice. Genomics 1989;5:91-9.
47. Wiedemann HR. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 1983; 141:129.
48. Henry I, Grandjouan JS, Couillin P, Barichard F, Huerre-Jeanpierre C, Glaser T, et al. Tumor-specific loss of 11p15.5 alleles in del 11p13 Wilms' tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A 1989;86:3247-51.
49. Yano T, Linehan M, Anglard P, Lerman MI, Daniel LN, Stein CA, et al. Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst 1989;81:518-23.
50. Miyamoto H, Kubota Y, Shuin T, Shiozaki H. Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci. Cancer Genet Cytogenet 1996;88: 181-3.
51. McNicol AM, Nolan CE, Struthers AJ, Farquharson MA, Hermans J, Haak HR. Expression of p53 in adrenocortical tumours: clinicopathological correlations. J Pathol 1997;181: 146-52.
52. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B. Linehan HM, et al. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. ] Clin Endocrinol Metab 1994;78:790-4.
53. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Saito S, Itakura M. Role of p53 in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res 1992;52:5061-4.
54. Lin S-R, Lee Y-J, Tsai J-H. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 1994;78:483-91.
55. Ohgaki H, Kleihues P, Heitz PU. p53 mutations in sporadic adrenocortical tumors, Int J Cancer 1993;54:408-10.
56. Grayson GH, Moore S, Schneider BG, Saldivar V, Hensel CH. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma. Am J Pediatr Hematol Oncol 1994;16:341-7.